2-74462305-C-T
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBS1_Supporting
The NM_006302.3(MOGS):c.1484G>A(p.Arg495Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000923 in 1,613,714 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R495P) has been classified as Likely benign.
Frequency
Consequence
NM_006302.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MOGS | NM_006302.3 | c.1484G>A | p.Arg495Gln | missense_variant | 4/4 | ENST00000448666.7 | NP_006293.2 | |
MOGS | NM_001146158.2 | c.1166G>A | p.Arg389Gln | missense_variant | 5/5 | NP_001139630.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MOGS | ENST00000448666.7 | c.1484G>A | p.Arg495Gln | missense_variant | 4/4 | 1 | NM_006302.3 | ENSP00000410992.3 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152180Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000149 AC: 37AN: 248460Hom.: 0 AF XY: 0.000171 AC XY: 23AN XY: 134864
GnomAD4 exome AF: 0.0000821 AC: 120AN: 1461534Hom.: 0 Cov.: 31 AF XY: 0.0000977 AC XY: 71AN XY: 727056
GnomAD4 genome AF: 0.000191 AC: 29AN: 152180Hom.: 0 Cov.: 33 AF XY: 0.000175 AC XY: 13AN XY: 74344
ClinVar
Submissions by phenotype
MOGS-congenital disorder of glycosylation Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 30, 2023 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 495 of the MOGS protein (p.Arg495Gln). This variant is present in population databases (rs34075781, gnomAD 0.06%). This variant has not been reported in the literature in individuals affected with MOGS-related conditions. ClinVar contains an entry for this variant (Variation ID: 534242). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MOGS protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Apr 21, 2023 | In silico analysis supports that this missense variant does not alter protein structure/function; Reported as a single heterozygous variant in a patient from a cohort of individuals diagnosed with CVID (PMID 33859323); This variant is associated with the following publications: (PMID: 36681659, 33859323) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at